N 6 -methyladenosine regulates glycolysis of cancer cells through PDK4

Studies on biological functions of N -methyladenosine (m A) modification in mRNA have sprung up in recent years. We find m A can positively regulate the glycolysis of cancer cells. Specifically, m A-sequencing and functional studies confirm that pyruvate dehydrogenase kinase 4 (PDK4) is involved in...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 11; no. 1; pp. 2578 - 16
Main Authors Li, Zihan, Peng, Yanxi, Li, Jiexin, Chen, Zhuojia, Chen, Feng, Tu, Jian, Lin, Shuibin, Wang, Hongsheng
Format Journal Article
LanguageEnglish
Published England Nature Portfolio 22.05.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Studies on biological functions of N -methyladenosine (m A) modification in mRNA have sprung up in recent years. We find m A can positively regulate the glycolysis of cancer cells. Specifically, m A-sequencing and functional studies confirm that pyruvate dehydrogenase kinase 4 (PDK4) is involved in m A regulated glycolysis and ATP generation. The m A modified 5'UTR of PDK4 positively regulates its translation elongation and mRNA stability via binding with YTHDF1/eEF-2 complex and IGF2BP3, respectively. Targeted specific demethylation of PDK4 m A by dm ACRISPR system can significantly decrease the expression of PDK4 and glycolysis of cancer cells. Further, TATA-binding protein (TBP) can transcriptionally increase the expression of Mettl3 in cervical cancer cells via binding to its promoter. In vivo and clinical data confirm the positive roles of m A/PDK4 in tumor growth and progression of cervical and liver cancer. Our study reveals that m A regulates glycolysis of cancer cells through PDK4.
ISSN:2041-1723
DOI:10.1038/s41467-020-16306-5